Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
40.64%
Change (1 year)
Categories
Revenue for Acorda Therapeutics (ACOR)
Revenue in 2023 (TTM): $0.11 B
According to Acorda Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.11 B. In 2022 the company made a revenue of $0.11 B a decrease over the years 2021 revenue that were of $0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Acorda Therapeutics from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.11 B | -0.79% |
| 2022 | $0.11 B | -8.14% |
| 2021 | $0.12 B | -15.62% |
| 2020 | $0.15 B | -20.5% |
| 2019 | $0.19 B | -59.19% |
| 2018 | $0.47 B | -19.86% |
| 2017 | $0.58 B | 13.22% |
| 2016 | $0.51 B | 5.47% |
| 2015 | $0.49 B | 22.71% |
| 2014 | $0.40 B | 19.34% |
| 2013 | $0.33 B | 10.01% |
| 2012 | $0.30 B | 4.65% |
| 2011 | $0.29 B | 53% |
| 2010 | $0.19 B | 249.35% |
| 2009 | $54.67 M | 14.32% |
| 2008 | $47.82 M | 21.12% |
| 2007 | $39.48 M | 44.37% |
| 2006 | $27.35 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.24 B | 956.96% | 🇺🇸 USA |
 Repligen
RGEN | $0.63 B | 443.01% | 🇺🇸 USA |
 Affimed
AFMD | $8.95 M | -92.38% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $2.41 B | 1,956.59% | 🇺🇸 USA |